Sources

58 main bibliography references · 12 additional references. 33 FAQ audit references with independent numbering

  1. Main bibliography · [1]

    [1] White WE. The Dextromethorphan FAQ. Text Version 4.0. 1997. Historical source; Section 13 and related warnings. Includes user reports.

    1997 · Separate verification unspecified

    Citations and related combinations →
  2. Main bibliography · [2]

    [2] AUVELITY prescribing information. DailyMed. Prescribing information: serotonin toxicity, MAOIs, CYP2D6, and bupropion. Accessed 2 October 2026. Source

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  3. Main bibliography · [3]

    [3] O’Mathúna B et al. The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans. J Clin Psychopharmacol. 2008;28(5):523–529. DOI 10.1097/JCP.0b013e318184ff6e. Human pharmacokinetic study; abstract and selected full-text methods, results and discussion checked for this proposed revision. Bibliographic pages: 523–529; the publisher PDF is printed as 525–531. Source

    2008 · Verified against the primary source · Full text · Abstract

    Citations and related combinations →
  4. Main bibliography · [4]

    [4] NUEDEXTA prescribing information. DailyMed. Prescribing information: metabolism, MAOIs, serotonin toxicity, and QT. Accessed 2 October 2026. Source

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  5. Main bibliography · [5]

    [5] Rickli A et al. Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome. Br J Pharmacol. 2018;175:532–543. DOI 10.1111/bph.14105. In vitro transporter experiments and clinical reports. Source

    2018 · Verified against the primary source · Full text

    Citations and related combinations →
  6. Main bibliography · [6]

    [6] Monte AA, Chuang R, Bodmer M. Dextromethorphan, chlorphenamine and serotonin toxicity: case report and systematic literature review. Br J Clin Pharmacol. 2010;70:794–798. DOI 10.1111/j.1365-2125.2010.03747.x. Cases primarily involve overdose. Source

    2010 · Separate verification unspecified

    Citations and related combinations →
  7. Main bibliography · [7]

    [7] Jung JK, Zazay I, Burmeister JR, Shaghaghi N. Serotonin syndrome induced by Bromfed DM in a patient on sertraline. SAGE Open Medical Case Reports. 2025. DOI 10.1177/2050313X251392069. Single case involving a multicomponent syrup. Source

    2025 · Separate verification unspecified

    Citations and related combinations →
  8. Main bibliography · [8]

    [8] Halman A et al. Drug–drug interactions involving classic psychedelics: A systematic review. 2024. DOI 10.1177/02698811231211219. General interaction literature; not a DXM combination trial. Source

    2024 · Separate verification unspecified

    Citations and related combinations →
  9. Main bibliography · [9]

    [9] Shen HW, Jiang XL, Winter JC, Yu AM. Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions. Curr Drug Metab. 2010;11(8):659–666. DOI 10.2174/138920010794233495. Source

    2010 · Separate verification unspecified

    Citations and related combinations →
  10. Main bibliography · [10]

    [10] Bansal S et al. Evaluation of Cytochrome P450 Mediated Cannabinoid Drug Interactions in Healthy Adult Participants. Clin Pharmacol Ther. 2023;114:693–703. DOI 10.1002/cpt.2973. Human CYP-probe study. Source

    2023 · Reported in the review · Review only

    Citations and related combinations →
  11. Main bibliography · [11]

    [11] Felmlee MA, Morse BL, Morris ME. γ-Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology. AAPS J. 2021;23(1):22. DOI 10.1208/s12248-020-00543-z. Source

    2021 · Separate verification unspecified

    Citations and related combinations →
  12. Main bibliography · [12]

    [12] FDA. Gabapentin and Pregabalin Drug Safety Communication. Respiratory safety warning; not a DXM study. Source

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  13. Main bibliography · [13]

    [13] UK Advisory Council on the Misuse of Drugs. Nitrous oxide updated harms assessment. 2023. Hypoxia and B12-related harms; not a DXM study. Source

    2023 · Separate verification unspecified

    Citations and related combinations →
  14. Main bibliography · [14]

    [14] NAMENDA prescribing information. DailyMed. Prescribing information notes insufficient assessment of NMDA-antagonist combinations. Accessed 2 October 2026. Source

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  15. Main bibliography · [15]

    [15] Suzuki J et al. Toxicities associated with NBOMe ingestion—a novel class of potent hallucinogens: a review of the literature. Psychosomatics. 2015. PMID 25659919. Source

    2015 · Separate verification unspecified

    Citations and related combinations →
  16. Main bibliography · [16]

    [16] Moss MJ, Hendrickson RG. Toxicity of muscimol and ibotenic acid containing mushrooms reported to a regional poison control center from 2002–2016. Clin Toxicol (Phila). 2019;57(2):99–103. Published online 2018. DOI 10.1080/15563650.2018.1497169. Source

    2019 · Separate verification unspecified

    Citations and related combinations →
  17. Main bibliography · [17]

    [17] Johnson MW, MacLean KA, Reissig CJ, Prisinzano TE, Griffiths RR. Human psychopharmacology and dose-effects of salvinorin A, a kappa-opioid agonist hallucinogen present in the plant Salvia divinorum. Drug Alcohol Depend. 2011;115:150–155. Source

    2011 · Separate verification unspecified

    Citations and related combinations →
  18. Main bibliography · [18]

    [18] Hamelin BA et al. Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity. Clin Pharmacol Ther. 2000;67(5):466–477. DOI 10.1067/mcp.2000.106464. Source

    2000 · Separate verification unspecified

    Citations and related combinations →
  19. Main bibliography · [19]

    [19] Schadel M, Wu D, Otton SV, Kalow W, Sellers EM. Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition. J Clin Psychopharmacol. 1995;15(4):263–269. DOI 10.1097/00004714-199508000-00005. Source

    1995 · Separate verification unspecified

    Citations and related combinations →
  20. Main bibliography · [20]

    [20] Shiran MR et al. A discordance between cytochrome P450 2D6 genotype and phenotype in patients undergoing methadone maintenance treatment. Br J Clin Pharmacol. 2003. PMID 12895196. Source

    2003 · Separate verification unspecified

    Citations and related combinations →
  21. Main bibliography · [21]

    [21] Grossman E et al. Oral yohimbine increases blood pressure and sympathetic nervous outflow in hypertensive patients. J Cardiovasc Pharmacol. 1993. PMID 7690091. Source

    1993 · Separate verification unspecified

    Citations and related combinations →
  22. Main bibliography · [22]

    [22] Di Marco MP, Edwards DJ, Wainer IW, Ducharme MP. The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein. Life Sci. 2002;71(10):1149–1160. DOI 10.1016/S0024-3205(02)01799-X. Source

    2002 · Verified against the primary source · Abstract

    Citations and related combinations →
  23. Main bibliography · [23]

    [23] Cai WM, Chen B, Ling SS, Zhang YD. Terbinafine-associated inhibition of dextromethorphan metabolism in Chinese subjects. Br J Clin Pharmacol. 2001;51(1):107–108. DOI 10.1046/j.1365-2125.2001.01322.x. Source

    2001 · Reported in the review · Review only

    Citations and related combinations →
  24. Main bibliography · [24]

    [24] Jacqz-Aigrain E, Funck-Brentano C, Cresteil T. CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humans. Pharmacogenetics. 1993;3(4):197–204. DOI 10.1097/00008571-199308000-00004. Source

    1993 · Separate verification unspecified

    Citations and related combinations →
  25. Main bibliography · [25]

    [25] American College of Medical Toxicology. Dextromethorphan FAQ. Educational material on poisoning and interactions. Source

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  26. Main bibliography · [26]

    [26] RASAGILINE prescribing information. DailyMed. DXM contraindication, including psychosis and unusual behavior warnings. Accessed 2 October 2026. Source

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  27. Main bibliography · [27]

    [27] Harada T et al. A fatal intoxication case due to the serotonin syndrome induced by dextromethorphan and moclobemide overdose. Leg Med (Tokyo). 2025;74:102604. DOI 10.1016/j.legalmed.2025.102604. Postmortem overdose report; not an estimate of outcome frequency. Source

    2025 · Separate verification unspecified

    Citations and related combinations →
  28. Main bibliography · [28]

    [28] Capon DA, Bochner F, Kerry N, Mikus G, Danz C, Somogyi AA. The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans. Clin Pharmacol Ther. 1996;60(3):295–307. PMID 8841152. DOI 10.1016/S0009-9236(96)90056-9. PK comparison between phenotypes and the effect of quinidine. Source

    1996 · Separate verification unspecified

    Citations and related combinations →
  29. Main bibliography · [29]

    [29] Tanna RS et al. Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom. Clin Pharmacol Ther. 2023;113:1315–1325. DOI 10.1002/cpt.2891. DXM as a probe after one low kratom exposure. Source

    2023 · Verified against the primary source · Full text

    Citations and related combinations →
  30. Main bibliography · [30]

    [30] ONDANSETRON prescribing information. DailyMed. QT effects and regulatory serotonin-syndrome warning. Accessed 2 October 2026. Source

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  31. Main bibliography · [31]

    [31] Rojas-Fernandez CH. Can 5-HT3 Antagonists Really Contribute to Serotonin Toxicity? A Call for Clarity and Pharmacological Law and Order. Drugs Real World Outcomes. 2014;1:3–5. DOI 10.1007/s40801-014-0004-3. Source

    2014 · Separate verification unspecified

    Citations and related combinations →
  32. Main bibliography · [32]

    [32] SCOPOLAMINE prescribing information. DailyMed. Anticholinergic effects, hyperthermia, and CNS interactions; extrapolation to DXM. Accessed 2 October 2026. Source

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  33. Main bibliography · [33]

    [33] PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE prescribing information. DailyMed. Sedation and other warnings for the therapeutic combination product. Accessed 2 October 2026. Source

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  34. Main bibliography · [34]

    [34] ZELAPAR selegiline prescribing information. DailyMed. DXM contraindication and limits of MAO-B selectivity. Accessed 2 October 2026. Source

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  35. Main bibliography · [35]

    [35] Khoshnam-Rad N et al. Datura poisoning in a family: Case series and literature review. Clin Case Rep. 2022. DOI 10.1002/ccr3.6091. Source

    2022 · Separate verification unspecified

    Citations and related combinations →
  36. Main bibliography · [36]

    [36] Health Canada. Canada launches new toll-free 1-844 POISON-X number for poison centres. 2023. Canadian poison-centre numbers and availability. Source

    2023 · Separate verification unspecified

    Citations and related combinations →
  37. Main bibliography · [37]

    [37] National Capital Poison Center. Use acetaminophen safely: Tips to prevent poisoning. Absence of early symptoms and prompt consultation for suspected overdose. Source

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  38. Main bibliography · [38]

    [38] National Capital Poison Center. First aid: Act fast! Immediate emergency response to collapse, seizures, impaired breathing, or inability to awaken. Source

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  39. Main bibliography · [39]

    [39] Hendershot PE, Antal EJ, Welshman IR, Batts DH, Hopkins NK. Linezolid: pharmacokinetic and pharmacodynamic evaluation of coadministration with pseudoephedrine HCl, phenylpropanolamine HCl, and dextromethorpan HBr. J Clin Pharmacol. 2001;41(5):563–572. DOI 10.1177/00912700122010302. Source

    2001 · Reported in the review · Review only

    Citations and related combinations →
  40. Main bibliography · [40]

    [40] LINEZOLID prescribing information. DailyMed. Direct DXM interaction findings in healthy volunteers. Accessed 2 October 2026. Source

    Year unspecified · Reported in the review · Review only

    Citations and related combinations →
  41. Main bibliography · [41]

    [41] Ramsay RR, Dunford C, Gillman PK. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. Br J Pharmacol. 2007. DOI 10.1038/sj.bjp.0707430. Source

    2007 · Separate verification unspecified

    Citations and related combinations →
  42. Main bibliography · [42]

    [42] Rivers N, Horner B. Possible lethal reaction between nardil and dextromethorphan. Can Med Assoc J. 1970;103(1):85. PMID 20311659. Source

    1970 · Separate verification unspecified

    Citations and related combinations →
  43. Main bibliography · [43]

    [43] Härtter S, Dingemanse J, Baier D, Ziegler G, Hiemke C. Inhibition of dextromethorphan metabolism by moclobemide. Psychopharmacology. 1998;135:22–26. DOI 10.1007/s002130050481. Source

    1998 · Separate verification unspecified

    Citations and related combinations →
  44. Main bibliography · [44]

    [44] XADAGO (safinamide) prescribing information. DailyMed. DXM contraindication and psychiatric rationale. Accessed 2 October 2026. Source

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  45. Main bibliography · [45]

    [45] Aarnoutse RE et al. Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers. Clin Pharmacol Ther. 2005;78(6):664–674. DOI 10.1016/j.clpt.2005.09.001. Source

    2005 · Verified against the primary source · Abstract

    Citations and related combinations →
  46. Main bibliography · [46]

    [46] Wyen C et al. Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients. Clin Pharmacol Ther. 2008. DOI 10.1038/sj.clpt.6100452. PMID 18183034. Source

    2008 · Reported in the review · Review only

    Citations and related combinations →
  47. Main bibliography · [47]

    [47] Canadian Association for Poison Centres and Clinical Toxicology. Poison-centre contacts and Nunavut public-access instructions. Accessed 2 October 2026. National contacts · Ontario centre and Nunavut instructions

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  48. Main bibliography · [48]

    [48] Health Canada. About the Good Samaritan Drug Overdose Act; Department of Justice Canada. Controlled Drugs and Substances Act, section 4.1. Accessed 2 October 2026. Official guidance · Statutory definition and protections

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  49. Main bibliography · [49]

    [49] Supreme Court of Canada. R. v. Wilson, 2025 SCC 32. 24 October 2025. Official case summary. Source

    2025 · Separate verification unspecified

    Citations and related combinations →
  50. Main bibliography · [50]

    [50] Amchin J et al. Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP2D6 probe. J Clin Pharmacol. 2001;41(4):443–451. DOI 10.1177/00912700122010159. Source

    2001 · Verified against the primary source · Abstract

    Citations and related combinations →
  51. Main bibliography · [51]

    [51] Tramadol hydrochloride tablets prescribing information. DailyMed. Prescribing information: 07/2024; Medication Guide: 10/2025. Accessed 16 October 2026. Source

    Year unspecified · Verified against the primary source · Prescribing information

    Citations and related combinations →
  52. Main bibliography · [52]

    [52] DEMEROL oral prescribing information. DailyMed. Prescribing information: 03/2021; oral tablets and solution. Accessed 16 October 2026. Source

    Year unspecified · Verified against the primary source · Prescribing information

    Citations and related combinations →
  53. Main bibliography · [53]

    [53] DOLOPHINE prescribing information. DailyMed. Prescribing information: 06/2021; Medication Guide: 12/2022. Accessed 16 October 2026. Source

    Year unspecified · Verified against the primary source · Prescribing information

    Citations and related combinations →
  54. Main bibliography · [54]

    [54] Codeine sulfate tablets prescribing information. Hikma Pharmaceuticals USA Inc. DailyMed. Revised 12/2025; updated 22 December 2025. Sections 5.2, 5.3, 5.6, 5.7, 12.3. Accessed 16 October 2026. Source

    2025 · Verified against the primary source · Prescribing information

    Citations and related combinations →
  55. Main bibliography · [55]

    [55] Crews KR et al. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy. Clin Pharmacol Ther. 2021;110(4):888–896. DOI 10.1002/cpt.2149. CPIC author PDF; pages 3–4, Codeine and Table 2. Source

    2021 · Separate verification unspecified

    Citations and related combinations →
  56. Main bibliography · [56]

    [56] Kolaczynska KE, Thomann J, Hoener MC, Liechti ME. The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative. Int J Mol Sci. 2021;22(15):8277. DOI 10.3390/ijms22158277. Human-transporter cell experiments. Source

    2021 · Separate verification unspecified

    Citations and related combinations →
  57. Main bibliography · [57]

    [57] Beck O, Franzén L, Bäckberg M, Signell P, Helander A. Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project. Clin Toxicol (Phila). 2016;54(7):568–575. DOI 10.1080/15563650.2016.1190979. Abstract accessed 16 October 2026; full text not read. Source

    2016 · Separate verification unspecified

    Citations and related combinations →
  58. Main bibliography · [58]

    [58] Franzén L, Bäckberg M, Beck O, Helander A. Acute Intoxications Involving α-Pyrrolidinobutiophenone (α-PBP): Results from the Swedish STRIDA Project. J Med Toxicol. 2018;14(4):265–271. DOI 10.1007/s13181-018-0668-2. Aggregate co-detection table; patient-level overlap of α-PVP and DXM unspecified. Source

    2018 · Separate verification unspecified

    Citations and related combinations →
  59. Additional reference

    India: Ministry of Home Affairs, Press Information Bureau. Shri Amit Shah launches Emergency Response Support System (ERSS - Dial 112), E-Beat Book System and E-Saathi App. 20 September 2019. Accessed 2026-10-19. https://www.pib.gov.in/PressReleasePage.aspx?PRID=1585706

    2019 · Separate verification unspecified

    Citations and related combinations →
  60. Additional reference

    CAPCCT national contacts. Accessed 2026-10-04.

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  61. Additional reference

    CAPCCT Ontario centre / Nunavut public route. Accessed 2026-10-04.

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  62. Additional reference

    CAPCCT Québec centre. Accessed 2026-10-04.

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  63. Additional reference

    China: State Council. Making phone calls in China. Inspected 2026-10-16. https://english.www.gov.cn/services/liveinchina/202008/04/content_WS5f29094bc6d029c1c2637342.html

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  64. Additional reference

    Health Canada Good Samaritan guidance. Accessed 2026-10-04.

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  65. Additional reference

    Health Canada POISON-X announcement. Accessed 2026-10-04.

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  66. Additional reference

    Justice Canada CDSA section 4.1. Accessed 2026-10-04.

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  67. Additional reference

    Nunavut community health centres. Accessed 2026-10-04.

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  68. Additional reference

    Supreme Court of Canada R. v. Wilson official Case in Brief. Accessed 2026-10-04.

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  69. Additional reference

    USA: National 911 Program. Calling 911. Inspected 2026-10-16. https://www.911.gov/calling-911/

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
  70. Additional reference

    МЧС России. Как правильно вызвать скорую? Accessed 2026-10-05.

    Year unspecified · Separate verification unspecified

    Citations and related combinations →
Reference

Open the source and related combinations →